All In Biotech

Drug Trial Radar · NCT01209234

Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

Last checked: Nov 20, 2026Latest source record: Nov 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 2,140 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,140

Actual

Start

Jan 2011

Primary completion

Jan 2019

Study completion Jan 2019

Sponsor

Lead sponsor
University of California, IrvineAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Agency for Healthcare Research and Quality (AHRQ)
First posted
Sep 27, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA-positive patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.

Conditions

  • Methicillin-resistant Staphylococcus Aureus

Interventions

  • Standard-of-Care EducationBehavioral

    Patients randomized to standard education will receive a binder with MRSA educational materials which will include or be based upon CDC guidance for MRSA patients at home.

  • MRSA DecolonizationDrug

    Participants in this arm will be instructed to complete a decolonization regimen that will involve a 5-day application of nasal mupirocin, oral CHG rinse, and CHG body wash twice a month.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to MRSA InfectionTime frame: 1 year

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • Covington Care Center

    Aliso Viejo, California

  • West Anaheim Extended Care

    Anaheim, California

  • Downey Regional Medical Center

    Downey, California

  • Fountain Valley Regional Hospital & Medical Center

    Fountain Valley, California

  • Orange Coast Memorial Medical Center

    Fountain Valley, California

  • St. Jude Medical Center

    Fullerton, California

  • Chapman Care Center

    Garden Grove, California

  • Pacific Haven HealthCare Center

    Garden Grove, California

  • Regents Point at Windcrest

    Irvine, California

  • Saddleback Memorial Medical Center - Laguna Hills

    Laguna Hills, California

  • Long Beach Memorial Medical Center

    Long Beach, California

  • St. Mary Medical Center

    Long Beach, California

  • Mission Hospital

    Mission Viejo, California

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California

  • Villa Elena Health Care Center

    Norwalk, California

  • UC Irvine Medical Center

    Orange, California

  • Saddleback Memorial Medical Center - San Clemente

    San Clemente, California

  • Little Company of Mary - San Pedro

    San Pedro, California

  • Country Villa Plaza

    Santa Ana, California

  • Royale Healthcare

    Santa Ana, California

  • Torrance Memorial Medical Center

    Torrance, California

  • Providence Little Company of Mary Medical Center

    Torrance, California

  • Harbor-UCLA Medical Center

    Torrence, California

  • Ventura County Medical Center

    Ventura, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.